Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597090 · ClinicalTrials.gov registry record
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 319
- Enrollment target
NCT00597090: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00597090 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 319 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597090 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 319 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand genetic susceptibility to infections and the interactions of specific genetic polymorphisms of innate immune receptors with microbial and fungal organisms. The goals of this study are: 1. Find out if some people are more likely to get severe infections, than others. To do this we will compare patients with leukemia who develop severe infections to patients who do not develop infections. 2. Find out if some people are more likely to develop lymphoma than others. To do this we will compare patients with lymphoma to people without lymphoma who are of the same sex and similar age and ethnic background to the patients with lymphoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2003-02 |
| Est. Completion | 2011-01 |
What the finished NCT00597090 record still lists
NCT00597090 is an observational study that tracks outcomes without assigning an intervention. The registered 319 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00597090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00597090 about?
NCT00597090 is a clinical study titled "The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections". The purpose of this study is to better understand genetic susceptibility to infections and the interactions of specific genetic polymorphisms of innate immune receptors with microbial and fungal organisms. The goals of this study are: 1. Find out if some people are more likely to get severe infect...
What is the current status of trial NCT00597090?
This trial is currently completed. The enrollment target is 319 participants. The study started on 2003-02. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00597090?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05377996 · 319 participants · Phase 1
A Study of XMT-1660 in Participants With Solid Tumors
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia